DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,504 filers reported holding DANAHER CORPORATION in Q4 2019. The put-call ratio across all filers is 1.66 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $10,960,000 | +7.6% | 77,500 | +9.9% | 0.07% | -1.4% |
| Q3 2019 | $10,189,000 | +4.2% | 70,548 | +3.4% | 0.07% | -1.4% |
| Q2 2019 | $9,774,000 | +11.4% | 68,243 | +2.7% | 0.07% | +6.0% |
| Q1 2019 | $8,774,000 | +31.1% | 66,467 | +2.4% | 0.07% | +11.7% |
| Q4 2018 | $6,691,000 | +2.0% | 64,907 | +7.5% | 0.06% | +9.1% |
| Q3 2018 | $6,560,000 | +19.8% | 60,370 | +7.9% | 0.06% | +7.8% |
| Q2 2018 | $5,476,000 | 0.0% | 55,974 | 0.0% | 0.05% | 0.0% |
| Q1 2018 | $5,476,000 | +10.7% | 55,974 | +5.0% | 0.05% | +8.5% |
| Q4 2017 | $4,948,000 | +14.0% | 53,315 | +5.3% | 0.05% | 0.0% |
| Q3 2017 | $4,341,000 | +2.0% | 50,611 | +0.3% | 0.05% | -6.0% |
| Q2 2017 | $4,255,000 | -1.8% | 50,440 | -0.4% | 0.05% | -9.1% |
| Q1 2017 | $4,333,000 | +25.9% | 50,636 | +14.7% | 0.06% | +14.6% |
| Q4 2016 | $3,441,000 | +186.3% | 44,143 | +187.7% | 0.05% | +166.7% |
| Q3 2016 | $1,202,000 | -21.0% | 15,345 | +2.0% | 0.02% | -25.0% |
| Q2 2016 | $1,522,000 | +1.9% | 15,047 | -4.4% | 0.02% | -7.7% |
| Q1 2016 | $1,494,000 | -0.6% | 15,744 | -2.8% | 0.03% | -7.1% |
| Q4 2015 | $1,503,000 | +28.0% | 16,195 | +17.2% | 0.03% | +16.7% |
| Q3 2015 | $1,174,000 | +20.5% | 13,813 | +21.3% | 0.02% | +33.3% |
| Q2 2015 | $974,000 | -1.2% | 11,386 | -1.8% | 0.02% | -5.3% |
| Q1 2015 | $986,000 | +24.3% | 11,597 | +25.0% | 0.02% | +5.6% |
| Q4 2014 | $793,000 | +82.7% | 9,275 | +62.3% | 0.02% | +50.0% |
| Q3 2014 | $434,000 | -4.8% | 5,714 | -1.3% | 0.01% | 0.0% |
| Q2 2014 | $456,000 | -9.3% | 5,790 | -13.7% | 0.01% | -20.0% |
| Q1 2014 | $503,000 | -5.1% | 6,711 | -2.7% | 0.02% | -6.2% |
| Q4 2013 | $530,000 | +11.3% | 6,895 | +1.7% | 0.02% | 0.0% |
| Q3 2013 | $476,000 | +56.1% | 6,779 | +44.0% | 0.02% | +45.5% |
| Q2 2013 | $305,000 | – | 4,707 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 217,436 | $53,823,432 | 13.80% |
| Defender Capital, LLC. | 152,962 | $37,949,802 | 13.74% |
| Bancreek Capital Management, LP | 60,890 | $15,106,809 | 13.58% |
| BOONE CAPITAL MANAGEMENT LLC | 129,163 | $32,045,340 | 10.11% |
| Eagle Health Investments LP | 175,085 | $43,438,589 | 9.57% |
| Third Point | 2,450,000 | $607,845,000 | 9.22% |
| Clio Asset Management LLC | 41,695 | $10,344,530 | 9.04% |
| Consulta Ltd | 500,000 | $124,050,000 | 8.91% |
| Riverstone Advisors, LLC | 47,960 | $11,799,701 | 8.16% |
| CADEN CAPITAL PARTNERS, LP | 123,755 | $27,215,377 | 7.66% |